Health Condition 1: C00-D49- Neoplasms
Conditions
Interventions
Intervention1: ERAS in HIPEC: we follow the steps of ERAS in HIPEC patients
once per patient
preop, intraop & post op
Control Intervention1: Not Applicable: Not Applicable
Sponsors
Nil
Eligibility
Inclusion criteria
Inclusion criteria: . Patients with a peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy ii. Peritoneal carcinomatosis Index (PCI) Score any iii. Age >18 years and iv. European Cooperative Oncology Group (ECOG) Performance status 0-1 vi. No functional disturbance in bone marrow; WBC at least 3,000/mm3, Platelet count of atleast125,000/mm3. vii. No functional disturbance in liver; Bilirubin less than 2.5 mg/dL, PT-INR viii. No function disturbance in kidney; Creatinine no greater than 1.5 times upper limit of normal.
Exclusion criteria
Exclusion criteria: Nil
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To assess the compliance of ERAS protocol in patients with peritoneal carcinomatosis undergoing CRS & HIPEC 2. To identify the correlation of the compliance pattern with morbidity & mortality Timepoint: 30 Days | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the length of ICU stay, hospital stay & factors associated with morbidity.Timepoint: 30 days | — |
Countries
India
Contacts
Public ContactDr Naveeth Shukkur
JIPMER, Pondicherry
Outcome results
None listed